Global Sunshine Reporting for HCP Engagement, US and Italian Transparency Reporting, Sunshine Laws, and Pharmaceutical Compliance
  • Home
  • ASK OUR EXPERTS
  • The Law
  • Events
    • Upcoming
    • Past
      • Workshop Sul Sunshine act Italiano
      • Gli obblighi derivanti dal Sunshine Act. Come prepararsi?
      • Sunshine Compliance Dialogue: Preparing for the Register
      • Sunshine Act Compliance Dialogue
      • TRANSPARENCY IN ITALY SUNSHINE REPORTING ESSENTIALS
      • Online Seminar
      • Italian Sunshine Report Hands-on workshop by experts
      • Italian Sunshine Law Unveiled: In-depth Insights from Leading Global Attorneys
      • Italian Sunshine Compliance Workshop
  • RESOURCES
    • BLOG
    • News
    • FAQ
    • Recommended Compliance Partners
    • Useful Links
  • About
  • Contact
  • en EN
    • en EN
    • it IT

Profile Picture
Register Login
Advertisement

Answer to Question 255520

by Riccardo Ovidi | Oct 29, 2025

Sì, se le soluzioni sono utilizzabili, ad esempio, per diagnosi, trattamento o decisioni cliniche. Rientrano quindi i CDSS, i software come dispositivi medici (SaMD) e gli strumenti di analisi dei dati sanitari (art. 2, comma 1, lett. a)).

Recent Posts

  • Sunshine Act Compliance Dialogue: A Gathering of Industry Leaders & Meaningful Conversations
  • Successful Italian Sunshine Report Hands-On Workshop Held in Milan
  • A Year in Review: Italian Sunshine Reporting’s Triumphs in 2023
  • Italian Sunshine Law Seminar Kicks Off with Resounding Success in Milan
  • Your Guides to Italian Sunshine Law: Two Must-Attend Events Revealed

Recent Comments

  1. Esiah Ehrnrooth on Transparency Consultation Update: Insights into Italy’s Telematic Register
  2. A WordPress Commenter on Transparency Consultation Update: Insights into Italy’s Telematic Register
  • The Law
  • News
  • Resources
  • FAQs
  • About
  • Contact
© 2025 Italian Sunshine Reporting. All rights reserved.